Here's Why Pfizer and BioNTech Are Selling Their Vaccine at Cost

Here's Why Pfizer and BioNTech Are Selling Their Vaccine at Cost

Source: 
Moltey Fool
snippet: 

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) recently agreed to sell their COVID-19 vaccine to the U.S. government at cost. In this video from Motley Fool Live, recorded on June 14, Fool.com contributors Brian Orelli and Keith Speights discuss why the companies would make such a move.